Showing results (541-550 of 626) with videos related to

Sort By:
Pageof 63
The Journal of Clinical Endocrinology and Metabolism|August 12, 2024
Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid CancerBhavana Konda, Eric J Sherman, Erminia Massarelli, et al.
Journal of Patient-Reported Outcomes|July 18, 2019
Patient reported outcomes can improve performance status assessment: a pilot studyJoan E Broderick, Marcella May, Joseph E Schwartz, et al.
Cancer Research|June 4, 2008
Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignanciesMario F Fraga, Maria Berdasco, Esteban Ballestar, et al.
Medical Care|June 27, 2017
Randomized Trial of Reducing Ambulatory Malpractice and Safety Risk: Results of the Massachusetts PROMISES ProjectGordon D Schiff, Harry Reyes Nieva, Paula Griswold, et al.
JCO Clinical Cancer Informatics|June 30, 2020
Quantified Kinematics to Evaluate Patient Chemotherapy Risks in ClinicZaki Hasnain, Tanachat Nilanon, Ming Li, et al.
BMC Cancer|April 18, 2018
RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomasPilar López-Nieva, Pablo Fernández-Navarro, Concepción Vaquero-Lorenzo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 28, 2017
Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse SurvivalDaniel J Boffa, Ryon P Graf, Michelle C Salazar, et al.
Chemistry & Biology|July 28, 2010
Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domainsCatarina R Vieira, Jose M Munoz-Olaya, Jesús Sot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at Least Four Cycles of Platinum-Based Chemotherapy: North Central Cancer Treatment Group (Alliance) N0923 StudyErin L Schenk, Sumithra J Mandrekar, Grace K Dy, et al.
Carcinogenesis|November 18, 2019
Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cellsLaura Gonzalez-Sanchez, Maria A Cobos-Fernandez, Pilar Lopez-Nieva, et al.
Pageof 63